The EMA announces further details on its move from current London headquarters to Amsterdam, which will begin on March 1 and see staff working in its new offices on March 11.
The Tjoa Group has launched Meditraq to help firms across the pharmaceutical supply chain meet data requirements, one year out from the EU serialization deadline.
DSM Sinochem Pharmaceuticals has licensed enzyme-based antibiotic production IP to Sandoz and accused Sinopharm Weiqida Pharmaceutical of patent infringement.
Wasting no time in furthering its lab-based JV with Quest Diagnostics the world’s largest CRO Quintiles has opened a GLP-compliant bioanalytical liquid chromatography-mass spectrometry (LC-MS) laboratory in Oss, the Netherlands.
Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.
Patheon brings fill/finish capabilities to DSM’s biomanufacturing services, President of Biopharma at the recently merged company DPx told Biopharma-Reporter.com in an exclusive interview.
Aurobindo says it can make the loss making European generics operations it is buying from Actavis profitable by combining them with its production network in India.
The Aspen Group, a generic pharmaceutical company, is moving further into the manufacturing business with the purchase of Merck’s API manufacturing sites in the Netherlands and Iowa.
With backing from the Australian Government, DSM has opened a mammalian cell culture operation to fuel the growing demand in the Asia-Pacific biologics market.
Chiltern International, a global contract research organisation (CRO) has expanded its European operations with the opening of a new office in the Netherlands.
DSM Speciality Intermediates (DSI) is to close by the end of 2010, with activities at its production site ceasing in July, in response to pricing pressures caused by the rise of rivals in India and China.
CMO SynCo Bio Partners has entered the Japanese biologics production market, which it views as a growth opportunity, by signing its first contract with an emerging company based in the country.
Diagnostics firm bioMérieux has announced plans to shift activities
at its facility in the Netherlands to France, shutting down the
Dutch site as it continues to haemorrhage cash.
US-based laboratory equipment specialist VWR International has
boosted its presence in Europe via the acquisition of Technical
Service Lab, a Dutch calibration and validation company.
The Netherlands has set up a programme to boost its biotechnology
sector by helping small and medium-sized biopharma firms to develop
and manufacture products, writes Phil Taylor.
Pharming of the Netherlands, which is pioneering the use of
transgenic animals for the production of biologics, has raised €7
million in new funding and will use the proceeds to advance its
portfolio of clinical drug candidates.
Dutch chemical company Akzo Nobel followed through on its plans to
cut costs at its pressured Diosynth subsidiary by slashing staff at
the unit, which has been hit by a deteriorating market for its
manufacturing services in both chemical...
Dutch life science company DSM reported this week that on Tuesday
three people were killed following an explosion at its Melamine
Plant 2 in Geleen, the Netherlands.
